News Sanofi's Dupixent scores double COPD win in US, China Originally anticipated in June, the FDA action stands to make Sanofi and Regeneron's biologic blockbuster even bigger.
News FDA clears two sickle-cell gene therapies, including CRISPR ... The US FDA has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
R&D Partner Content 5th Annual Gene Therapy Analytical Development Summit 2023 Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development.
News FDA approves GSK’s oral treatment of dialysis anaemia The US Food and Drug Administration (FDA) has approved the
News FDA says no to Astellas' geographic atrophy drug Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US.
Digital Sponsored Decoding physician prescribing behaviour: A data-driven jour... Identifying high-volume prescribers and engaging with key opinion leaders (KOLs) in a target therapeutic area can be a challenge.
